DAA136 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
Molecular |
brain |
Human |
ME3 |
5.0% Decrease Gene Expression Level |
|
DAA218 |
syndecan 2 |
Molecular |
brain |
Human |
SDC2 |
25.0% Increase Gene Expression Level |
|
DAA196 |
receptor (G protein-coupled) activity modifying protein 1 |
Molecular |
brain |
Human |
RAMP1 |
16.0% Increase Gene Expression Level |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
277.8% Increase Gene Expression Level |
|
DAA238 |
Thy-1 cell surface antigen |
Molecular |
brain |
Human |
THY1 |
7.0% Decrease Gene Expression Level |
|
DAA2340 |
MHC class I polypeptide-related sequence B increases with age |
Molecular |
parietal lobe |
Human |
MICB |
39.9% Increase Gene Expression Level |
|
DAA27 |
chromosome 1 open reading frame 95 |
Molecular |
brain |
Human |
C1orf95 |
5.0% Decrease Gene Expression Level |
|
DAA2279 |
CD163 molecule increases with age |
Molecular |
parietal lobe |
Human |
CD163 |
488.1% Increase Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2264 |
Caspase 1, (interleukin 1, beta, convertase) increases with age |
Molecular |
parietal lobe |
Human |
CASP1 |
53.3% Increase Gene Expression Level |
|
DAA230 |
spondin 1, extracellular matrix protein |
Molecular |
brain |
Human |
SPON1 |
21.0% Increase Gene Expression Level |
|
DAA2138 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
temporal lobe |
Human |
FCGR1A |
151.0% Increase Gene Expression Level |
|
DAA2203 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
56.5% Increase Gene Expression Level |
|
DAA149 |
Norrie disease (pseudoglioma) |
Molecular |
brain |
Human |
NDP |
9.0% Increase Gene Expression Level |
|
DAA93 |
guanine nucleotide binding protein (G protein), gamma 11 |
Molecular |
brain |
Human |
GNG11 |
23.0% Increase Gene Expression Level |
|
DAA2152 |
complement component 4B increases with age |
Molecular |
parietal lobe |
Human |
C4B |
444.8% Increase Gene Expression Level |
|
DAA1096 |
Prostaglandin E Receptor 3 (subtype EP3) |
Molecular |
temporal lobe |
Human |
PTGER3 |
Increase DNA Methylation |
|
DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA2331 |
major histocompatibility complex, class I, E increases with age |
Molecular |
hippocampus |
Human |
HLA-E |
39.2% Increase Gene Expression Level |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
Molecular |
frontal lobe |
Human |
C1S |
71.9% Increase Gene Expression Level |
|
DAA2373 |
major histocompatibility complex, class I, B increases with age |
Molecular |
hippocampus |
Human |
HLA-B |
44.0% Increase Gene Expression Level |
|
DAA1224 |
MTHFR methylation decrease |
Molecular |
prefrontal cortex |
Human |
— |
— |
|
DAA2315 |
major histocompatibility complex, class II, DP alpha 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DPA1 |
262.9% Increase Gene Expression Level |
|
DAA191 |
poliovirus receptor-related 3 |
Molecular |
brain |
Human |
PVRL3 |
20.0% Decrease Gene Expression Level |
|
DAA2295 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
temporal lobe |
Human |
CX3CL1 |
46.7% Decrease Gene Expression Level |
|